Auleon Biologicals
News
14
2024
-
08
Huapi Bio Group, a leading company in mobile insurance, completed its first financing, with Guoxin Hongsheng, a well-known industrial party and Jinmu Capital participating in the investment, and Kaby Capital acting as the sole financial advisor.
Author:
Recently, Huabai Biotechnology (Group) Co., Ltd. (referred to as "Huabai Bio") completed its first financing. Guoxin Hongsheng's Sichuan-Yu Guanghong Fund and a well-known industry side, Jinmu Capital and other participation in the investment. Kay Capital serves as the exclusive financial advisor.
Huapai Bio is a group animal protection enterprise focusing on the research and development, production, sales and technical services of animal protection products such as veterinary biological vaccines, antibodies, diagnostic reagents, veterinary drugs, etc., with more than 30 years of industry accumulation. The group has successively built high-standard Huapai Group Headquarters, Chongqing Aolong, Chongqing Yongjian, Tengchong Huayu, Zhuji Gaoling 5 veterinary biological products production bases and Chengdu Essence Pharmaceutical production base. At present, there are 22 veterinary biological product production lines and 21 animal drug production lines, including China's first nucleic acid vaccine production line that has passed GMP ("Good Manufacturing Practice") acceptance, 1 fully automated production line for virus-like particle vaccine, and 3 Cell suspension culture production lines. There are more than 50 veterinary vaccine products and more than 300 animal drugs. The production scale and production capacity of biological products and animal drugs are in the forefront of the industry.
Huabai Biological Group is the only company in the animal health industry that fully covers the five major animal vaccines of foot-and-mouth disease, echinococcosis, peste des petits ruminants, brucellosis and avian influenza. Around the five strong immune vaccines, three-dimensional layout of veterinary biological products field, comprehensive coverage of pigs, poultry, cattle, sheep, rabbits and other commercial animals, with the industry's most comprehensive product line layout, and forward-looking layout of the pet plate, has a wealth of product reserve pipeline.
At present, with its full coverage of biological vaccines, animal health drugs and all-round technical services, Huabai Biological Group can effectively solve the pain points and difficulties of many breeding group customers, and has become the preferred brand for various large breeding groups to prevent and control epidemics. Help my country's animal epidemic prevention, zoonotic disease prevention and control, and animal-derived food safety system construction.
Kaby Capital said: Animal diseases affect the national economy and people's livelihood, and the development prospects of the animal protection market are broad. Huapi Bio Group is a very scarce and mature target in the field of animal health, and has a strong explosive power. The company's product layout is comprehensive, R & D strength is strong, and has a solid sales system, comprehensive strength is extremely strong. We wish Huapai Biological Group, with the blessing of capital and resources from all parties, with more than 30 years of profound accumulation, accelerated development and set sail!
Introduction to Investment Institutions: Sichuan-Chongqing Guanghong Fund was jointly initiated and established by Guoxin Hongsheng and Sichuan Guang 'an Investment Group. It focuses on investing in sub-sectors such as raw materials, chemical preparations, proprietary Chinese medicines, biological products, medical devices, medical and aesthetic raw materials, medical services, etc. in the field of medicine and health, and makes every effort to enable the high-quality development of medicine and health advantage industries in the Shuangcheng Economic Circle in Chengdu-Chongqing region.
Kay by Capital partially successful deal
Innovative drugs: xiantong Medicine | Kangle Guardian | Haichuang Medicine | Green Bamboo Biology | Homologous Kang Medicine | Xuan Bamboo Biology | Hui Sheng Biology | Jun Hemeng | Andu Biology | Jin Lan Gene | Qi Yu Biology | Chang Xi Pharmaceutical | Qing Pu Biology | Heyuan Biology | Suikun Intelligence | Nuo Wei Biology | Hongyun Biology | Kang Pu Biology | Bo Aoxin | Zedeman | Mass Peptide Biology | Enze Taikang | Arthur Medicine | Youjia Biology | Sai Yuan Biology | Zhongying Technology | Spectrum New Biology | Huateng Pharmaceutical | Baino | Wujia and Gene
Equipment & Consumer Medical Care: Li Kai Technology | Tupai Medical Care | Hua Xin Medical Care | DPM Digital Precision | Wei Zhuo Zhiyuan | Chang Mu Gu | Boen Ruier | English Life | Yijiada | Di Shi Medical Care | 3N Technology | An Song Technology | Wan Jie Tianyuan | Yao Shi Medical Care | Xin Yan Technology | Zhu Rong Medical Care | Maidi Peak | Dakang Medical Care | Good Mood | Rong Quan Medicine
Life Science & IVD: Deep Research Biology | Miaoshun Biology | Aso Science and Technology | Huixiang Science and Technology | Yatong Biology | Huijian Science and Technology | Konomi | Nomi Metabolism | Agian
Agricultural Food Science and Technology & Biological Manufacturing: Boredi | Grannon | Lanmei Stock | Aidijing | Ding Holding Biology | Qingke Biology | Hua Hao Zhongtian | Zhi He Biology | Baikui Rui Biology | Yan Micro Technology
Kaicheng Capital (WinX Capital) is China's leading investment bank in the large health sector, headquartered in Beijing and Shanghai, covering more than 3000 active investment institutions and industrial groups. It has won many honors such as the first new voice "TOP 1 of financial advisory institutions in the medical and health field in 2022 and 2023", the enterprise business card & new voice creation service "TOP 2 of best financial advisory institutions in the medical and health field in 2021-2022", and the arterial network "2022-2024 top 100 of future medical and health financial advisory of the year.
Latest Blog
2024-08-22
"Passion Foying Gorge Swims in the Water World"-A Documentary of Aolong Biology 2024 'Gratitude Tour
From August 15 to 18, 2024, Chongqing aolong biological products co., ltd. successfully held the "passionate Buddha shadow gorge swimming in the water world"-aolong biological 2024 'cohesion and gratitude tour group building activity,
2024-08-14
Huapi Bio Group, a leading company in mobile insurance, completed its first financing, with Guoxin Hongsheng, a well-known industrial party and Jinmu Capital participating in the investment, and Kaby Capital acting as the sole financial advisor.
Recently, Huabai Biotechnology (Group) Co., Ltd. (referred to as "Huabai Bio") completed its first financing.
Thank you for visiting the official website of Chongqing Auleon Biologicals. If you have cooperation intentions or suggestions, please contact us through the following methods, and we will give you feedback in time, thank you!
Marketing Center: +86-023-46761801
Technical Services: +86-023-46763511
HR: +86-023-46763267
International Trade: +86-023-46763211
Address: (No.5, 4th Branch Road) National High-tech Industrial Park, Rongchang District, Chongqing, China
© 2024 Chongqing Auleon Biologicals Co., Ltd. 
渝公网安备50022602000038号